{"schema_version":"secwatch.filing_event.v1","accession":"0001178913-22-003312","form_type":"8-K","ticker":"ENTXW","cik":"0001638097","company_name":"Entera Bio Ltd.","filed_at":"2022-09-02T23:59:59+00:00","discovered_at":"2026-05-14T18:03:56.488509+00:00","generated_at":"2026-06-23T16:34:04.819732+00:00","sec_items":["1.01","8.01","9.01"],"event_type":"other_material","sentiment":"neutral","materiality_score":0.5,"calibrated_materiality_score":0.5,"confidence":"high","headline":"Entera Bio enters into $5M ATM equity facility with SVB; terminates prior B. Riley ATM","bullets":["Entered Sales Agreement with SVB Securities for at-the-market offering of up to 5,000,000 ordinary shares.","Agent commission set at 3.0% of gross sales price per ordinary share sold.","Prior B. Riley Securities ATM terminated effective Aug 30, 2022; no shares were sold under it.","Net proceeds planned for general corporate purposes including R&D, clinical trials, and working capital."],"urls":{"canonical":"https://secwatch.observer/filing/0001178913-22-003312","json":"https://secwatch.observer/filing/0001178913-22-003312.json","markdown":"https://secwatch.observer/filing/0001178913-22-003312.md","text":"https://secwatch.observer/filing/0001178913-22-003312.txt","edgar_index":"https://www.sec.gov/Archives/edgar/data/1638097/000117891322003312/0001178913-22-003312-index.htm","edgar_primary_document":"https://www.sec.gov/Archives/edgar/data/1638097/000117891322003312/zk2228415.htm"},"model":{"generated_by":"deepseek-v4-flash:cloud@v2","generated_at":"2026-06-23T16:34:04.819732+00:00"},"review":{"review_status":"machine_generated","human_reviewed":false,"corrected":false,"correction_note":null,"correction_timestamp":null,"superseded_by":null,"related_filings":[]},"source_grounded_claims":[],"license":"Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer"}